Citi lowered the firm’s price target on Lam Research (LRCX) to $80 from $87 and keeps a Buy rating on the shares. The firm lowered its 2025 and ...

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...